Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, MiRNA-based therapy for acute respiratory distress syndrome: MiRNA-29b inhibits acute lung injury via down regulation of its target gene, 12/April/2015, 11.48 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: This study suggests, for the first time, that MiRNA-29b, by suppressing the expression of its target gene, it may inhibit acute lung injury. Thereby, it may inhibit the progression of acute respiratory distress syndrome. Thus, pharmacological formulations encompassing “MiRNA-29b or its activators” may be used to inhibit the progression of acute respiratory distress syndrome.
Amount: $ 300
Undisclosed information: How MiRNA-29b inhibits the progression of acute respiratory distress syndrome
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
